A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose ...

Advanced colorectal cancer presents significant clinical challenges owing to its propensity for metastatic dissemination and the development of chemoresistance. Contemporary management strategies ...

Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + ...

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to ...

Initial Dose Adjustment of Zolbetuximab Plus Chemotherapy in CLDN18.2-Positive Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer (GENTLE-Z), a Randomized, Phase II Trial ...

Colorectal cancer is the fourth-most-common cancer in the U.S. and the second deadliest. One in 5 patients is diagnosed with metastatic disease, meaning the colorectal cancer has spread beyond the ...

Immunotherapeutic strategies have made huge strides in cancer treatment for many solid tumors over the past decade. But the promising results have failed to make a large change in the treatment of ...

The surgical outcomes of colon cancer vary with its anatomical location. Neoadjuvant chemotherapy can aid in improving the postsurgical outcomes of both right and left colon cancer, decreasing the ...

Researchers have developed and internally validated a simple score using clinical factors that can help estimate the likelihood of advanced colorectal neoplasia in adults younger than age 45 years.

Colorectal cancer remains the third most commonly diagnosed cancer in both men and women in the United States, with approximately 153,000 new cases expected this year alone. While overall rates have ...

Add Yahoo as a preferred source to see more of our stories on Google. For oncologist Timothy Cannon, alarm bells first sounded in 2019, when, within six months, he treated three fit, young patients ...